CYTOKINETICS INC (CYTK)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About CYTOKINETICS INC
Cytokinetics, Incorporated is a NASDAQ-listed biotechnology company focused on discovering, developing, and commercializing novel muscle activators and muscle inhibitors for cardiac and skeletal muscle diseases. Its business is centered in the United States, and it generated $88.0 million in revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
CYTOKINETICS INC's Technical Indicators Summary
CYTK exhibits short- to medium-term downside pressure, with momentum indicators and MACD below neutral and CCI in negative territory, while short moving averages sit above the price and the classic pivot rests slightly higher. ADX is low, indicating a weak directional trend, but on-balance volume favors selling and ATR shows elevated volatility around the high single-digit percent range, which accentuates recent weakness. Technical takeaway: Momentum and moving averages favor a sell bias in the short to medium term despite longer-term average support.
| Indicator | Value |
|---|---|
RSI (14) | 42.98 |
Stochastic %K (14, 3, 3) | 23.30 |
CCI (20) | -119.05 |
WPR (14) | -78.45 |
Momentum (10) | -1.84 |
MFI | 37.02 |
MACD Level (12, 26) | -0.86 |
Bollinger Bands | $75.39 - $83.03 |
ATR (14) | $2.95 (3.86%) |
ADX (14) | 12.48 |
OBV | 53,232,633 |
Classic Pivot Point | $77.23 |
Fibonacci Pivot Point | $77.23 |
Simple Moving Averages | $68.69 - $79.21(5 indicators) |
Exponential Moving Averages | $68.33 - $78.94(5 indicators) |
Get premium market insights delivered directly to your inbox.